Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |